Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haemodynamic Effect of Dexmedetomidine and Autonomic Activity
NCT02566863Phase 4Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Jun 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in sedation, sponsored by Medical University of Gdańsk. Primary endpoint: Changes of haemodynamics and heart rate variability parameters up to 30 minutes. Started Jun 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT02566863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02566863.